Main Article Content
Abstract
Background: Retinopathy of prematurity (ROP) is a leading cause of preventable childhood blindness, and middle-income countries face a third epidemic as neonatal survival outpaces screening capacity. Indonesian data using the third ICROP edition are scarce.
Objective: To describe the ICROP third-edition phenotype distribution among Indonesian infants with ROP and evaluate the associations of severity with gestational age and birth weight using exact inference and partial identification.
Methods: This retrospective STROBE-compliant study characterised the ICROP phenotype of 39 infants with ROP at a tertiary referral hospital in Denpasar between January 2020 and December 2022, and examined severity against gestational age and birth weight. Proportions carry 95% Wilson intervals; the gestational-age-by-stage cross-classification was reconstructed under the published marginals, tested by exact methods, and bounded across every reconstruction.
Results: Mean gestational age was 28.7 ± 2.7 weeks and mean birth weight was 1091 ± 320 g; 94.9% were of very low birth weight. Stage was documented for 38 infants: stage 1, 68.4%; stage 2, 28.9%; and stage 3, 2.6%. Pre-plus and plus disease each affected 7.7%, and aggressive ROP affected 2.6%. Stage ≥2 occurred in 70.0% of infants born before 28 weeks versus 17.9% of those born later (odds ratio 9.16, 95% CI 1.90–44.10; exact P = 0.005; Cramér’s V = 0.370), with a monotone trend across strata (exact P = 0.004). Across all 30 admissible reconstructions, the exact P ranged from 0.004 to 0.115 and the odds ratio from 0.03 to 9.16. Birth weight carried no usable information because 94.9% of the cohort occupied a single stratum.
Conclusion: Gestational age, not birth weight, should anchor ROP surveillance intensity in Indonesian tertiary units, while a broad birth-weight entry threshold is retained.
Keywords
Article Details
Scientific Journal of Pediatrics (SJPed) allow the author(s) to hold the copyright without restrictions and allow the author(s) to retain publishing rights without restrictions, also the owner of the commercial rights to the article is the author.
